Search research articles
Contact Us
Filters
Showing results (311-320 of 483) with videos related to
Page
of 49
Sort By:
The Journal of Biological Chemistry
|
January 19, 2020
Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ
Scott M Ebert, Steven A Bullard, Nathan Basisty, et al.
Frontiers in Immunology
|
June 30, 2023
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy
Chad Pickering, Paul Aiyetan, Gege Xu, et al.
ESMO Open
|
September 11, 2024
mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
R-D Hofheinz, F Herrle, T Dechow, et al.
ESMO Open
|
February 22, 2025
Corrigendum to "mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)": [ESMO Open 9 (2024) 103703]
R-D Hofheinz, F Herrle, T Dechow, et al.
Cancer Research
|
January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design
Lisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Geroscience
|
April 4, 2023
The transcription regulator ATF4 is a mediator of skeletal muscle aging
Matthew J Miller, George R Marcotte, Nathan Basisty, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 31, 2019
ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle
Jordan D Fuqua, Caleb P Mere, Ana Kronemberger, et al.
Oncotarget
|
June 25, 2016
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome
Lih Yin Tan, Chris Mintoff, M Zahied Johan, et al.
Science Advances
|
October 25, 2023
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma
Brett W Stringer, Manam Inushi De Silva, Zarina Greenberg, et al.
The Journal of Nutrition
|
December 27, 2021
Biology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy
Scott M Ebert, Blake B Rasmussen, Andrew R Judge, et al.
Page
of 49
Search research articles
Search
Showing results (311-320 of 483) with videos related to
Sort By:
Page
of 49
The Journal of Biological Chemistry
|
January 19, 2020
Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ
Scott M Ebert, Steven A Bullard, Nathan Basisty, et al.
Frontiers in Immunology
|
June 30, 2023
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy
Chad Pickering, Paul Aiyetan, Gege Xu, et al.
ESMO Open
|
September 11, 2024
mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
R-D Hofheinz, F Herrle, T Dechow, et al.
ESMO Open
|
February 22, 2025
Corrigendum to "mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)": [ESMO Open 9 (2024) 103703]
R-D Hofheinz, F Herrle, T Dechow, et al.
Cancer Research
|
January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design
Lisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Geroscience
|
April 4, 2023
The transcription regulator ATF4 is a mediator of skeletal muscle aging
Matthew J Miller, George R Marcotte, Nathan Basisty, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 31, 2019
ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle
Jordan D Fuqua, Caleb P Mere, Ana Kronemberger, et al.
Oncotarget
|
June 25, 2016
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome
Lih Yin Tan, Chris Mintoff, M Zahied Johan, et al.
Science Advances
|
October 25, 2023
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma
Brett W Stringer, Manam Inushi De Silva, Zarina Greenberg, et al.
The Journal of Nutrition
|
December 27, 2021
Biology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy
Scott M Ebert, Blake B Rasmussen, Andrew R Judge, et al.
Page
of 49